DrugPatentWatch Database Preview
Blueprint Medicines Company Profile
Email this page to a colleague
What is the competitive landscape for BLUEPRINT MEDICINES, and what generic alternatives to BLUEPRINT MEDICINES drugs are available?
BLUEPRINT MEDICINES has one approved drug.
There are three US patents protecting BLUEPRINT MEDICINES drugs.
There are thirty-five patent family members on BLUEPRINT MEDICINES drugs in thirty countries and ten supplementary protection certificates in ten countries.
Summary for Blueprint Medicines
| International Patents: | 35 |
| US Patents: | 3 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Blueprint Medicines
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Blueprint Medicines | AYVAKIT | avapritinib | TABLET;ORAL | 212608-001 | Jan 9, 2020 | RX | Yes | No | 9,944,651 | ⤷ Try it Free | Y | Y | ⤷ Try it Free | ||
| Blueprint Medicines | AYVAKIT | avapritinib | TABLET;ORAL | 212608-003 | Jan 9, 2020 | RX | Yes | Yes | 9,994,575 | ⤷ Try it Free | Y | Y | ⤷ Try it Free | ||
| Blueprint Medicines | AYVAKIT | avapritinib | TABLET;ORAL | 212608-004 | Jun 16, 2021 | RX | Yes | No | 9,200,002 | ⤷ Try it Free | Y | Y | ⤷ Try it Free | ||
| Blueprint Medicines | AYVAKIT | avapritinib | TABLET;ORAL | 212608-005 | Jun 16, 2021 | RX | Yes | No | ⤷ Try it Free | ⤷ Try it Free | |||||
| Blueprint Medicines | AYVAKIT | avapritinib | TABLET;ORAL | 212608-005 | Jun 16, 2021 | RX | Yes | No | 9,944,651 | ⤷ Try it Free | Y | Y | ⤷ Try it Free | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Blueprint Medicines Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Spain | 2683127 | ⤷ Try it Free |
| Japan | 2019048878 | ⤷ Try it Free |
| Serbia | 57542 | ⤷ Try it Free |
| World Intellectual Property Organization (WIPO) | 2015057873 | ⤷ Try it Free |
| Mexico | 365614 | ⤷ Try it Free |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Blueprint Medicines Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 3057969 | 301094 | Netherlands | ⤷ Try it Free | PRODUCT NAME: AVAPRITINIB EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; REGISTRATION NO/DATE: EU/1/20/1473 20200925 |
| 3057969 | 132021000000035 | Italy | ⤷ Try it Free | PRODUCT NAME: AVAPRITINIB E SUOI SALI FARMACEUTICAMENTE ACCETTABILI(AYVAKYT); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/20/1473, 20200925 |
| 3057969 | 10/2021 | Austria | ⤷ Try it Free | PRODUCT NAME: AVAPRITINIB UND PHARMAZEUTISCH ANNEHMBARE SALZE DAVON; REGISTRATION NO/DATE: EU/1/20/1473 (MITTEILUNG) 20200925 |
| 3057969 | C202130012 | Spain | ⤷ Try it Free | PRODUCT NAME: AVAPRITINIB Y SALES FARMACEUTICAMENTE ACEPTABLES DEL MISMO; NATIONAL AUTHORISATION NUMBER: EU/1/20/1473; DATE OF AUTHORISATION: 20200924; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/20/1473; DATE OF FIRST AUTHORISATION IN EEA: 20200924 |
| 3057969 | 122021000014 | Germany | ⤷ Try it Free | PRODUCT NAME: AVAPRITINIB UND PHARMAZEUTISCH VERTRAEGLICHE SALZE DAVON; REGISTRATION NO/DATE: EU/1/20/1473 20200924 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
